First-pass extracted concept

brain organoids

Candidate: concept label2 source documents2 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Aliases

brain-organoid models

Evidence Snippets

Genome-editing innovations... facilitate precise and reversible modulation of psychiatric risk genes, particularly when combined with induced pluripotent stem cell (iPSC) and brain-organoid models.

Evidence 1Source 1DOI PubMedprovenance

We discuss the current trend of combinational applications of μFCs with other neuro- and biotechnologies, including optogenetics, brain organoids, and 3D bioprinting, for better multiscale brain research.

Evidence 2Source 2DOI PubMedprovenance

Supporting Sources

Source 1primary paper2025MEDDOI PubMed

1 evidence snippet 1 linked claim Claim 1

Source 2review2020Lab on a ChipDOI PubMed

1 evidence snippet 1 linked claim Claim 1

Linked Claims

Claim 1contextual combinationsupports2025Source 1DOI PubMed

The utility of next-generation genome editing for psychiatric risk gene modulation is particularly highlighted when combined with iPSC and brain-organoid models.

Claim 2combination strategysupports2020Source 2DOI PubMed

The review highlights a trend toward combining microfluidic chips with optogenetics, brain organoids, and 3D bioprinting for better multiscale brain research.

Quoted textsource-backed

We discuss the current trend of combinational applications of μFCs with other neuro- and biotechnologies, including optogenetics, brain organoids, and 3D bioprinting, for better multiscale brain research.